aminochrome 1 has been researched along with 1,1-diethyl-2-hydroxy-2-nitrosohydrazine in 1 studies
| Studies (aminochrome 1) | Trials (aminochrome 1) | Recent Studies (post-2010) (aminochrome 1) | Studies (1,1-diethyl-2-hydroxy-2-nitrosohydrazine) | Trials (1,1-diethyl-2-hydroxy-2-nitrosohydrazine) | Recent Studies (post-2010) (1,1-diethyl-2-hydroxy-2-nitrosohydrazine) |
|---|---|---|---|---|---|
| 76 | 0 | 31 | 258 | 0 | 45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cacho, J; Crespo, MD; Herrera, E; Klatt, P; Ramos, P | 1 |
1 other study(ies) available for aminochrome 1 and 1,1-diethyl-2-hydroxy-2-nitrosohydrazine
| Article | Year |
|---|---|
Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist.
Topics: 3T3 Cells; Adipocytes; Animals; Catecholamines; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Hydrazines; Indolequinones; Indoles; Isoproterenol; Lipolysis; Mice; Molsidomine; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Oxygen; Rats; Rats, Wistar; Signal Transduction; Spectrophotometry; Time Factors; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 2000 |